Scott P. Bruder, MD, PhD
Founder & CEO

James M. Petricek, MSE, MBA
Vice President

Susan Drapeau, PhD
Vice President

Kristen D. Allen, RAC
Engagement Partner
Quality & Regulatory AffaIrs
Strategy & Submissions

Douglas M. Arm, PhD
Engagement Partner 
Technology, Development
& Operations

Spencer B. Bailey, MBA, CPC
Engagement Partner
Reimbursement &
Health Economics

Lisa M. Bruder, MEd
Artistic Director
& Logistics

Chris Fair
Engagement Partner 
Business Development
& Diligence

Sumitra Ghate, RAC
Engagement Partner
Regulatory Affairs
Strategy & Submissions

Philip Lavin, PhD, FASA, FRAPS
Engagement Partner 
Biostatistics & Regulatory, Clinical, Commercial Strategy

Rebecca Marshall, MS, MBA
Engagement Partner 
Strategic Planning &
Market Development 

Gloria Polito
Executive Adminstrative 
Assistant

Patrick Reischling, MBS
Engagement Partner
Clinical Affairs and Strategy

Nicola Selley
Engagement Partner
Regulatory Affairs
Strategy & Submissions

Suzanne Tabbaa, PhD
Engagement Partner
Technology & Diligence

Charlie Boy, DOG
Canis Associate

Nilla Wafer, DOG
Chief Canine Officer, Emeritus

Roy K. Aaron, MD
Orthopaedic Surgery &
Translational Research

Arnold I. Caplan, PhD
Cell Therapy &
Biologics

Steven A. Goldstein, PhD
Biomedical Engineering
& Orthopaedics

Andrew J. Nelson, MD
Orthopaedic Surgery
& Diligence

MCRA is the leading privately held independent medical device and biologics Clinical Research Organization (CRO) and advisory firm. MCRA has offices in Washington, DC, Hartford, CT, and New York, NY, and serves more than 700 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, general surgery, digital health, neurology, robotics, and in vitro diagnostic (IVD) devices. Dr. Bruder has coordinated with MCRA to provide Client Partners with both clinical and regulatory support in their pursuit of data generation and marketing approvals.

InnovAito is a pre-eminent patent monetization advisory service turning patents into revenues. Our proprietary approach to patent portfolio analysis unlocks tremendous value for our clients looking for competitiveness in the market.  We are a think tank providing services for creation of highest quality patents from inventions, utilizing cutting edge artificial intelligence tool and machine learning at the patent claims level. We have an experienced team that has unlocked the revenue potential from multibillion dollar research budgets and worked with Fortune 500 companies, universities and SMEs. Dr. Bruder has partnered with Innovaito to provide clients with insights and action plans regarding their patent estate.

L.E.K. Consulting advises MedTech leaders on identifying new growth opportunities, enhancing profitability, and providing insight to manage all phases of transaction services. Their clients include eight of the 10 largest global MedTech companies, as well as emerging businesses. Their deep expertise across the life sciences, and healthcare spectrum enables them to understand how MedTech providers may be affected by hospital purchasing trends, payer reimbursement strategies, advances with companion diagnostics, and other market dynamics. Dr. Bruder is a member of the L.E.K. Life Science and MedTech Expert Network.

Wombat Capital is a New York City-based investment banking and strategic advisory firm.  The company's business team, supported by its Advisory Board, the strategic and Financial network of its Directors and the close relationships developed with numerous companies, provide Wombat Capital with unparalleled access and insight.  Dr. Bruder serves as Senior Advisor, Orthopedics and Regenerative Medicine.